ATE419828T1 - Epsilon-polylysin gegen halitose - Google Patents

Epsilon-polylysin gegen halitose

Info

Publication number
ATE419828T1
ATE419828T1 AT04803351T AT04803351T ATE419828T1 AT E419828 T1 ATE419828 T1 AT E419828T1 AT 04803351 T AT04803351 T AT 04803351T AT 04803351 T AT04803351 T AT 04803351T AT E419828 T1 ATE419828 T1 AT E419828T1
Authority
AT
Austria
Prior art keywords
phosvitin
conjugated
casein phosphopeptide
partially
epsilon
Prior art date
Application number
AT04803351T
Other languages
English (en)
Inventor
Lucas Huybrechts
Original Assignee
Lucas Huybrechts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lucas Huybrechts filed Critical Lucas Huybrechts
Application granted granted Critical
Publication of ATE419828T1 publication Critical patent/ATE419828T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/88—Polyamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Polyamides (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04803351T 2004-01-19 2004-11-29 Epsilon-polylysin gegen halitose ATE419828T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE2004/0028A BE1015863A6 (nl) 2004-01-19 2004-01-19 Anticariogene proteinen & peptiden & sacchariden.

Publications (1)

Publication Number Publication Date
ATE419828T1 true ATE419828T1 (de) 2009-01-15

Family

ID=34754164

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04803351T ATE419828T1 (de) 2004-01-19 2004-11-29 Epsilon-polylysin gegen halitose

Country Status (13)

Country Link
US (1) US20080226565A1 (de)
EP (1) EP1709069B1 (de)
JP (1) JP2007523891A (de)
CN (1) CN1922203A (de)
AT (1) ATE419828T1 (de)
BE (1) BE1015863A6 (de)
BR (1) BRPI0418420A (de)
CA (1) CA2553613A1 (de)
DE (1) DE602004018985D1 (de)
DK (1) DK1709069T3 (de)
ES (1) ES2320001T3 (de)
RU (1) RU2006129942A (de)
WO (1) WO2005068645A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0702021D0 (en) * 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
JP2009143874A (ja) * 2007-12-17 2009-07-02 Chisso Corp オーラルケア製品
JP2010160863A (ja) * 2009-01-09 2010-07-22 Hitachi Ltd 光ディスク装置及び多層式ディスク
CN101838467B (zh) * 2010-05-21 2013-05-29 南京农业大学 一种新型壳聚糖纳米颗粒及其制备方法
DE102011077067A1 (de) * 2011-06-07 2012-12-13 Beiersdorf Ag Wirkstoffkombinationen aus å-Polylysin (Epsilon-Polylysin) und einem odermehreren aromatischen Aldehyden
BR112014014459A2 (pt) 2011-12-15 2017-06-13 Colgate Palmolive Co composições para cuidados orais
EP2826785B1 (de) * 2012-03-13 2017-08-09 National University Corporation Okayama University Lysinoligomerderivat und daraus hergestellter knorpelgewebemarker
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
CN103932914B (zh) * 2013-09-03 2016-06-08 浙江康德药业集团股份有限公司 壳聚糖漱口液及其制备方法
KR101664444B1 (ko) * 2013-12-13 2016-10-12 재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소 생분해성 의료용 접착제 또는 실란트 조성물
GB201409451D0 (en) 2014-05-28 2014-07-09 Ipabc Ltd Antimicrobial preparations, methods for preparing the same and uses thereof to combat microorganisms
CN104248775B (zh) * 2014-09-22 2015-11-25 片仔癀（上海）生物科技研发有限公司 一种羟基磷灰石-壳聚糖复合凝胶及其制备工艺与用途
CN106446599A (zh) * 2015-08-11 2017-02-22 中国科学院青岛生物能源与过程研究所 一种筛选婴幼儿龋病的口腔致病性生物标记物的方法
CN105767419A (zh) * 2016-04-06 2016-07-20 俞祖勋 一种防龋齿糖果的制造方法
WO2018168997A1 (ja) * 2017-03-16 2018-09-20 江崎グリコ株式会社 歯牙の再石灰化を促進できる口腔用組成物
CN107233228A (zh) * 2017-07-20 2017-10-10 杭州坦珮信息技术有限公司 一种防口臭和龋齿牙膏的制造方法
JP7198453B2 (ja) * 2019-01-30 2023-01-04 国立研究開発法人産業技術総合研究所 リグニンスルホン酸とε－ポリリジンを成分とするイオン複合材料
EP4178622A4 (de) * 2020-07-07 2024-11-20 BET Bioscience Extraction Technologies Inc. Phosphinzusammensetzungen und verfahren zur herstellung und verwendung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015628A (en) * 1986-06-12 1991-05-14 The University Of Melbourne Anticariogenic phosphopeptides
JP3114359B2 (ja) * 1992-05-14 2000-12-04 チッソ株式会社 抗う蝕および抗歯周病剤
US5587147A (en) * 1994-06-30 1996-12-24 Church & Dwight Co., Inc. Aqueous zinc-polyamide complex solution
AUPR517701A0 (en) * 2001-05-21 2001-06-14 University Of Melbourne, The Dental restorative materials
US7589070B2 (en) * 2001-06-15 2009-09-15 The Children's Hospital Of Philadelphia Surface modification for improving biocompatibility
JP3862013B2 (ja) * 2002-09-13 2006-12-27 ライオン株式会社 口腔用組成物

Also Published As

Publication number Publication date
WO2005068645B1 (en) 2005-12-08
US20080226565A1 (en) 2008-09-18
JP2007523891A (ja) 2007-08-23
WO2005068645A3 (en) 2005-11-10
RU2006129942A (ru) 2008-02-27
EP1709069A2 (de) 2006-10-11
DK1709069T3 (da) 2009-05-11
CA2553613A1 (en) 2005-07-28
DE602004018985D1 (de) 2009-02-26
BRPI0418420A (pt) 2007-05-15
BE1015863A6 (nl) 2005-10-04
ES2320001T3 (es) 2009-05-18
CN1922203A (zh) 2007-02-28
WO2005068645A2 (en) 2005-07-28
EP1709069B1 (de) 2009-01-07

Similar Documents

Publication Publication Date Title
BRPI0418420A (pt) proteìnas, peptìdeos e sacarìdeos anticariogênicos
WO2008118017A3 (en) Prame derived peptides and immunogenic compositions comprising these
WO2003020756A3 (en) Hybrid and tandem expression of neisserial proteins
EA199900979A1 (ru) Композиции активированного протеина
BR0108173A (pt) Composições farmacêuticas de toxina de botulina
DE60001914D1 (de) Mehrzweck zusammensetzungen von säuren
UA106869C2 (uk) Поліпептид ace2
WO2003093314A3 (en) Connective tissue stimulating peptides
NO20091441L (no) Rekonstituerte surfaktanter med forbedrede egenskaper
BR0012919A (pt) Vacina para uso na profilaxia e/ou no tratamento da sìndrome de ponto branco (white spot syndrome) em crustáceos, proteìna estrutural derivada do vìrus da sìndrome de ponto branco, sequência de ácido nucléico, uso de uma proteìna estrutural, composição farmacêutica, anticorpos, vacina ou formulação farmacêutica, e, kit diagnóstico para detecção de wssv
ITMI20041567A1 (it) "derivati n-acilati di acidi bicarbossilici con amminoacidi e con idrolizzati proteici vegetali e loro applicazione in prodotti cosmetici, dermofarmaceutici e farmaceutici"
BRPI0607097B8 (pt) uso de um peptídeo imunogênico para a fabricação de um medicamento para o tratamento, prevenção ou redução de infecção por papilomavírus
TR200401793T4 (tr) Perindopril tuzu ve bunu içeren farmasötik bileşimler.
SE0002202D0 (sv) New peptides
ATE430165T1 (de) Peptide mit integrinbindungsmotiv und behandlungsmethoden für muskelkrankheiten
ATE211391T1 (de) Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung
ATE364999T1 (de) Modifizierte lupinproteine zur herstellung einer wasser-dispergierbaren produktform fettlöslicher stoffe
WO2007048086A3 (en) Canine influenza virus and related compositions and methods of use
BRPI0314546B8 (pt) composição de gel farmacêutico compreendendo peptídeos farmaceuticamente atvos com liberação sustentada, método para a produção dos mesmos kit.
BR0316493A (pt) ésteres de ácido aldÈnico, métodos para produzir os mesmos, e métodos para produzir ingredientes ativos farmacêuticos ligados a polissacarìdicos ou derivados polissacarìdeos sobre grupos amino livres
ATE362756T1 (de) Schmerzfreie injektions-zubereitungen von 2- arylpropionsäuresalzen
BRPI0511005A (pt) peptìdeos oligoméricos e seu uso para o tratamento de infecções por hiv
BR0307048A (pt) Composição farmacêutica orodispersìvel de perindoprila
ATE552271T1 (de) Antitumorarzneimittel, medikament, zusammensetzung und anwendung davon
WO2009105780A3 (en) Mntf peptide compositions and methods of use

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1709069

Country of ref document: EP

REN Ceased due to non-payment of the annual fee